Worldwide Ankylosing Spondylitis Treatment Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4355104
- 133 Pages
- March 2021
- Healthcare
The global ankylosing spondylitis treatment market is anticipated to grow at a consistent cagr with 2030
Ankylosing spondylitis treatment market players focusing on development & regulatory authorizations
The United States and Canada and also Europe jointly make up greater than 50% of market share, revenue concentrated in the us and also eu4
Inclusion of nanocurcumin to reinforce the ankylosing spondylitis therapy market in the projection duration
Ankylosing spondylitis therapy market analysis
As per arthritis treatment & research study, practically 20-50% of individuals dealing with ankylosing spondylitis are reported to reveal spinal progression of particular degree in the last two years of follow-up.
The tnf inhibitor treatments as well as nsaids (non-steroid anti-inflammatory medicines) have actually been keystone treatments relating to managing ankylosing spondylitis and also other kinds of inflammatory joint inflammation conditions.
The European congress of rheumatology (eular) annual meeting provided a french research raising a concern that rheumatologists, in spite of being well-informed regarding biosimilars, abstain from changing over to them because of lack of self-confidence in this therapy alternative.
On the various other hand, European journal of integrative medication, sep 2019, specified that moxibustion, a sort of warmth therapy incorporated with typical treatments is likely to offer short-term advantage to the ones impacted by ankylosing spondylitis. this therapy is currently placed into technique throughout east Asia.
Besides, searchings for at the universita degli studi del molise (Italy) state that physiotherapy is advantageous for ankylosing spondylitis-affected people.
Though anti-inteleukin medicines as well as anti-tumor death have actually boosted prognosis for a large variety of patients; physiotherapy aids those who do not react positively to these drugs. furthermore, modern day treatments press for physical rehab and also therapy.
Of late, research study carried out at the college of clinical sciences (Iran) ended that t reg cells (reducing the immune system) were upregulated in ankylosing spondylitis-affected individuals that received a dosage of nanocurcumin for 4 months straight. turmeric has curcumin in the kind of a naturally-occurring yellow colored compound.
The variables mentioned above are expected to urge the governments to draw away a greater portion of their revenue towards comprehensive research study, thus driving the ankylosing spondylitis treatment market.
Market gamers are concentrating on r& d and advancements the ankylosing spondylitis treatment market players are concentrating on development and also approval to gain an one-upmanship over one another.
This trend is bound to help the ankylosing spondylitis market stand in a better stead between 2020 and also 2030.
For example, in jun 2020, Germany-based real-world information stated that simponi (golimumab), a tnf inhibitor, is just one of the most efficient therapies for ankylosing spondylitis-affected individuals.
In feb 2020, taltz (ixekizumab) was approved by wellness Canada for dealing with grownups with ankylosing spondylitis who werent receptive to standard therapies.
In dec 2019, avsola (infliximab-axxq), biosimilar to remicade (infliximab) for dealing with ankylosing spondylitis, was approved by the us fda. amgen is the maker of this biosimilar.
In nov 2019, abbvie, at 2019 American university of rheumatology (acr)/ organization for rheumatology specialists (arp) annual conference, provided favorable arise from phase 2 & 3 select-axis 1 test for therapy against ankylosing spondylitis in the type of rinvoq.
In nov 2019, the us fda approved abrilada (adalimumab-afzb), biosimilar to humira (adalimumab) for dealing with people infected with 7 inflammatory conditions (ankylosing spondylitis included). abrilada is credited to pfizer.
In sep 2019, end result of stage 2 research that analyzed filgotinib suggested that dental treatment might verify to be a reliable therapy concerning energetic ankylosing spondylitis.
Covid-19 effect on ankylosing spondylitis market
Ankylosing spondylitis infected people require to be added cautious in the middle of covid-19. if they, whatsoever, signal towards energetic breathing infection, they must consult their physician prior to continuing with the drugs as that infection could be covid-19, which may request a mix of different medications/precautions.
Ankylosing spondylitis treatment market patterns
The medical care industry is relocating in the direction of considerable research with concerns to ankylosing spondylitis, so regarding proceed with the geometric progression on the matter of advancements.
In jun 2020, celltrion medical care got suggestion from chmp (committee for medicinal products for human use) for use of remsima in ankylosing spondylitis.
In oct 2019, saa (spondylitis organization of America) became part of collaboration with patientpoint for enhancing education pertaining to spondylitis and additionally expand assistance to rheumatology techniques around the us.
Ankylosing spondylitis treatment market: regional analysis
The United States and Canada holds the biggest share of ankylosing spondylitis treatment market due to viable repayment circumstance in the us combined with enormous authorizations for biosimilars by the us fda.
European ankylosing spondylitis treatment market is gaining from federal governments buying research study regarding efficient treatment for ankylosing spondylitis.
Asia pacific is expected to witness a linear change in the ankylosing spondylitis treatment market as a result of countries like India and China relocating from indolence to understanding regarding ankylosing spondylitis therapy
Significant gamers in the ankylosing spondylitis therapy market
The ankylosing spondylitis treatment market players have actually been designing biosimilars to fight ankylosing spondylitis.
Likewise, well-known drugs license expiry is opening doors for biosimilars. for circumstances, remicade ended in 2015. this caused inflectra getting presented in 2016. the year 2017 saw introduction of renflexis. similarly, in 2019, avsola obtained presented.
The significant gamers in the ankylosing spondylitis therapy market consist of:
Wyeth
Mitsubishi tanabe
Schering-plough
Takeda
Amgen
Centocor
Abbott
Eisai
Pfizer
Ankylosing spondylitis therapy market: the method forward
The ankylosing spondylitis treatment market, as mentioned by We, is expected to witness a constant growth rate between 2020 and 2030.
The market gamers are working with battle footing to develop medications for ankylosing spondylitis.
Inorganic growth criteria might also be considered around. as an example, strategic collaborations across different locations might aid within bent on even more number of patients
Key section
Medicine class
Nonsteroidal anti-inflammatory medicines
Anti-inflammatory medicines
Immunosuppressive drugs
Tnf blockers
Jak inhibitors
Steroids
Biologics
Others
Course of management
Parenteral
Oral
Application
Grownups
Juveniles
Area
North America
Latin America
Europe
Eastern Asia
South Asia
Oceania
Center eastern and also Africa
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Ankylosing Spondylitis Treatment by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Ankylosing Spondylitis Treatment Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Ankylosing Spondylitis Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Ankylosing Spondylitis Treatment Production from 2014-2020
4.3.1.2 North America Ankylosing Spondylitis Treatment Consumption from 2014-2020
4.3.1.3 North America Ankylosing Spondylitis Treatment Import and Export from 2014-2020
4.3.1.4 North America Ankylosing Spondylitis Treatment Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Ankylosing Spondylitis Treatment Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Ankylosing Spondylitis Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Ankylosing Spondylitis Treatment Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Ankylosing Spondylitis Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Ankylosing Spondylitis Treatment Production from 2014-2020
4.3.2.2 Europe Ankylosing Spondylitis Treatment Consumption from 2014-2020
4.3.2.3 Europe Ankylosing Spondylitis Treatment Import and Export from 2014-2020
4.3.2.4 Europe Ankylosing Spondylitis Treatment Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Ankylosing Spondylitis Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Ankylosing Spondylitis Treatment Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Ankylosing Spondylitis Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Ankylosing Spondylitis Treatment Production from 2014-2020
4.3.3.2 Asia-Pacific Ankylosing Spondylitis Treatment Consumption from 2014-2020
4.3.3.3 Asia-Pacific Ankylosing Spondylitis Treatment Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Ankylosing Spondylitis Treatment Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Ankylosing Spondylitis Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Ankylosing Spondylitis Treatment Production from 2014-2020
4.3.4.2 Latin America Ankylosing Spondylitis Treatment Consumption from 2014-2020
4.3.4.3 Latin America Ankylosing Spondylitis Treatment Import and Export from 2014-2020
4.3.4.4 Latin America Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Ankylosing Spondylitis Treatment Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Ankylosing Spondylitis Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Ankylosing Spondylitis Treatment Production from 2014-2020
4.3.5.2 Middle East & Africa Ankylosing Spondylitis Treatment Consumption from 2014-2020
4.3.5.3 Middle East & Africa Ankylosing Spondylitis Treatment Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Ankylosing Spondylitis Treatment Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Ankylosing Spondylitis Treatment Market from 2020-2026
7.1 Future Forecast of Global Ankylosing Spondylitis Treatment Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Ankylosing Spondylitis Treatment Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Ankylosing Spondylitis Treatment Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
619 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Ankylosing Spondylitis Treatment Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Ankylosing Spondylitis Treatment Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Ankylosing Spondylitis Treatment
Figure Type 2 of Ankylosing Spondylitis Treatment
Figure Type 3 of Ankylosing Spondylitis Treatment
Table Global Ankylosing Spondylitis Treatment Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Ankylosing Spondylitis Treatment Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Ankylosing Spondylitis Treatment
Figure Application 2 of Ankylosing Spondylitis Treatment
Figure Application 3 of Ankylosing Spondylitis Treatment
Table Global Ankylosing Spondylitis Treatment Production Value ($) by Regions
Table Global Ankylosing Spondylitis Treatment Production Value Share by Regions
Table Global Ankylosing Spondylitis Treatment Production by Regions
Table Global Ankylosing Spondylitis Treatment Production Share by Regions
Table Global Ankylosing Spondylitis Treatment Consumption by Regions
Table Global Ankylosing Spondylitis Treatment Consumption Share by Regions
Figure North America Ankylosing Spondylitis Treatment Production and Growth Rate from 2014-2020
Figure North America Ankylosing Spondylitis Treatment Consumption and Growth Rate from 2014-2020
Table North America Ankylosing Spondylitis Treatment Import and Export from 2014-2020
Table North America Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Type from 2019-2020
Table North America Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Application from 2019-2020
Table North America Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Ankylosing Spondylitis Treatment Participants Value ($) and Market Share (%) in 2020
Figure Europe Ankylosing Spondylitis Treatment Production and Growth Rate from 2014-2020
Figure Europe Ankylosing Spondylitis Treatment Consumption and Growth Rate from 2014-2020
Table Europe Ankylosing Spondylitis Treatment Import and Export from 2014-2020
Table Europe Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Europe Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Europe Ankylosing Spondylitis Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Ankylosing Spondylitis Treatment Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Ankylosing Spondylitis Treatment Production and Growth Rate from 2014-2020
Figure Asia-Pacific Ankylosing Spondylitis Treatment Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Ankylosing Spondylitis Treatment Import and Export from 2014-2020
Table Asia-Pacific Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Ankylosing Spondylitis Treatment Participants Value ($) and Market Share (%) in 2020
Figure Latin America Ankylosing Spondylitis Treatment Production and Growth Rate from 2014-2020
Figure Latin America Ankylosing Spondylitis Treatment Consumption and Growth Rate from 2014-2020
Table Latin America Ankylosing Spondylitis Treatment Import and Export from 2014-2020
Table Latin America Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Ankylosing Spondylitis Treatment Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Ankylosing Spondylitis Treatment Production and Growth Rate from 2014-2020
Figure Middle East & Africa Ankylosing Spondylitis Treatment Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Ankylosing Spondylitis Treatment Import and Export from 2014-2020
Table Middle East & Africa Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Ankylosing Spondylitis Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Ankylosing Spondylitis Treatment Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Ankylosing Spondylitis Treatment Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Ankylosing Spondylitis Treatment Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Ankylosing Spondylitis Treatment Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Ankylosing Spondylitis Treatment Production and Growth Rate Forecast by Types (2020-2026)
Table Global Ankylosing Spondylitis Treatment Consumption and Growth Rate Forecast by End-User/Applications (2020-2636)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
